n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with prostaglandin d2 in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 16 (61.54) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kudo, I; Matsumoto, H; Murakami, M; Naraba, H; Oh-ishi, S; Ueno, A; Yamaki, K | 1 |
| Lau, HY; Stenton, GR | 1 |
| Kaminski, DL; Longo, WE; Mazuski, J; Panesar, N | 1 |
| Abbracchio, MP; Bonazzi, A; Brambilla, R; Burnstock, G; Cattabeni, F; Ceruti, S | 1 |
| Chivers, J; Colville-Nash, PR; Gilroy, DW; Paul-Clark, MJ; Willis, D; Willoughby, DA | 1 |
| Feinstein, DL; Heneka, MT; Klockgether, T | 1 |
| Di Rosa, M; Ialenti, A; Ianaro, A; Maffia, P; Pisano, B | 1 |
| Arm, JP; Diaz, BL; Fujishima, H; Kanaoka, Y; Urade, Y | 1 |
| Cheuk, BL; Chew, SB; Fiscus, RR; Wong, PY | 1 |
| Asakura, K; Hata, S; Hayasaki-Kajiwara, Y; Hori, Y; Kuroda, T; Nakazato, H; Sakaeda, T; Takasu, N; Ueda, K; Yagami, T | 1 |
| Campell, WB; Isbell, MA; Kajdacsy-Balla, A; Kaul, S; Lindholm, PF; Nithipatikom, K | 1 |
| Corbett, L; Knox, AJ; Nie, M; Pang, L | 1 |
| Arm, JP; Bonventre, JV; Diaz, BL; Fujishima, H; Sapirstein, A | 1 |
| Bjorling, DE; Calamon-Dixon, JL; Jerde, TJ; Nakada, SY | 1 |
| García-Bueno, B; Leza, JC; Lizasoain, I; Lorenzo, P; Madrigal, JL; Moro, MA | 1 |
| Hegab, AE; Iizuka, T; Ishii, Y; Itoh, K; Kimura, T; Kiwamoto, T; Matsuno, Y; Mochizuki, M; Morishima, Y; Nomura, A; Sakamoto, T; Sekizawa, K; Uchida, K; Yamamoto, M | 1 |
| Ashkenazi, S; Vanichkin, A; Weizman, A; Yuhas, Y | 1 |
| Arai, I; Futaki, N; Hashimoto, Y; Honma, Y; Nakaike, S; Sugimoto, M | 1 |
| Araki, E; Ishii, N; Itabe, H; Kawada, T; Kim-Mitsuyama, S; Matsumura, T; Motoshima, H; Murata, Y; Nishikawa, T; Senokuchi, T; Taketa, K; Takeya, M; Tsuruzoe, K; Yano, M | 1 |
| Eichele, K; Hinz, B; Ramer, R | 1 |
| Dercho, RA; Di Francesco, A; Di Francesco, L; Dovizio, M; Evangelista, V; Pandolfi, A; Patrignani, P; Piccoli, A; Salvatore, T; Seta, F; Totani, L | 1 |
| Arai, Y; Higuchi, H; Kohjitani, A; Maeda, S; Miyawaki, T; Shimada, M; Tomoyasu, Y | 1 |
| Abraki, SB; Khalaj, L; Khodagholi, F; Shaerzadeh, F | 1 |
| Emmrich, K; Hinz, B; Mittag, N; Ramer, R; Walther, U | 1 |
| Choi, YH; Kang, JL; Lee, YJ; Park, YM; Yoon, YS | 1 |
| Iwasa, K; Maruyama, K; Yagishita, S; Yamamoto, S; Yoshikawa, K | 1 |
1 review(s) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and prostaglandin d2
| Article | Year |
|---|---|
Participation of cytosolic phospholipase A2 in eicosanoid generation by mouse bone marrow-derived mast cells.
Topics: Animals; Bone Marrow Cells; Cyclooxygenase Inhibitors; Cytosol; Eicosanoids; Mast Cells; Mice; Nitrobenzenes; Phospholipases A; Phospholipases A2; Prostaglandin D2; Sulfonamides | 2002 |
1 trial(s) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and prostaglandin d2
| Article | Year |
|---|---|
Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells.
Topics: Adult; Anti-Anxiety Agents; Cyclooxygenase 2 Inhibitors; Drug Synergism; Female; Humans; Interleukin-6; Leukocytes, Mononuclear; Lipopolysaccharides; Male; Midazolam; Nitrobenzenes; Prostaglandin D2; Sulfonamides | 2012 |
24 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and prostaglandin d2
| Article | Year |
|---|---|
Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages.
Topics: Animals; Cells, Cultured; Cycloheximide; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dactinomycin; Dinoprostone; Enzyme Induction; Indomethacin; Intramolecular Oxidoreductases; Isoenzymes; Isomerases; Kinetics; Lipopolysaccharides; Macrophage Activation; Macrophages, Peritoneal; Male; Nitrobenzenes; Prostaglandin D2; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sulfonamides; Thromboxane B2 | 1997 |
Effects of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 specific inhibitors on mediator release from rat peritoneal mast cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Activation; Flurbiprofen; Histamine Release; Ibuprofen; Immunoglobulin E; Indans; Indomethacin; Isoenzymes; Male; Mast Cells; Naphthaleneacetic Acids; Nitrobenzenes; Peritoneal Cavity; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sulfonamides | 1998 |
Contribution of cyclooxygenase-1 and cyclooxygenase-2 to prostanoid formation by human enterocytes stimulated by calcium ionophore and inflammatory agents.
Topics: Calcimycin; Calcium; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Eicosanoids; Epithelial Cells; Humans; Immunoblotting; Interleukin-1; Intestinal Mucosa; Isoenzymes; Lipopolysaccharides; Membrane Proteins; Nitrobenzenes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyrazoles; Salicylates; Sulfonamides; Tetradecanoylphorbol Acetate | 1998 |
Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis.
Topics: Adenosine Triphosphate; Animals; Aspirin; Astrocytes; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Gliosis; Isoenzymes; Nitrobenzenes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Receptors, Purinergic P2; Sulfonamides; Time Factors | 1999 |
Inducible cyclooxygenase may have anti-inflammatory properties.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Indomethacin; Inflammation; Isoenzymes; Male; Membrane Proteins; Monocytes; Neutrophils; Nitrobenzenes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Sulfonamides | 1999 |
Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Death; Cerebellum; Chromans; Cyclooxygenase Inhibitors; Down-Regulation; Ibuprofen; Immunohistochemistry; In Situ Nick-End Labeling; Interferon-gamma; Ligands; Lipopolysaccharides; Male; Microinjections; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sulfonamides; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2000 |
Role of cyclopentenone prostaglandins in rat carrageenin pleurisy.
Topics: Active Transport, Cell Nucleus; Animals; Carrageenan; Cyclooxygenase Inhibitors; Disease Models, Animal; DNA-Binding Proteins; Drug Combinations; Exudates and Transudates; Heat Shock Transcription Factors; Heat-Shock Proteins; HSP72 Heat-Shock Proteins; Humans; Indomethacin; Male; NF-kappa B; NF-kappa B p50 Subunit; Nitrobenzenes; Pleura; Pleurisy; Prostaglandin D2; Prostaglandins; Rats; Rats, Wistar; Sulfonamides; Transcription Factor RelA; Transcription Factors | 2001 |
Regulation of prostaglandin endoperoxide synthase-2 and IL-6 expression in mouse bone marrow-derived mast cells by exogenous but not endogenous prostanoids.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Marrow Cells; Cells, Cultured; Cyclooxygenase 2; Cytokines; Dinoprostone; Interleukin-6; Isoenzymes; Male; Mast Cells; Mice; Mice, Inbred BALB C; Nitrobenzenes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Sulfonamides | 2002 |
Cyclooxygenase-2 regulates apoptosis in rat epididymis through prostaglandin D2.
Topics: Animals; Apoptosis; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; DNA Fragmentation; Electrophoresis, Capillary; Epididymis; Fluorescence; In Situ Nick-End Labeling; Isoenzymes; Lasers; Male; Membrane Proteins; Nitrobenzenes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Sulfonamides | 2002 |
Group IB secretory phospholipase A2 induces neuronal cell death via apoptosis.
Topics: Animals; Apoptosis; Arachidonic Acid; Carbamates; Cell Survival; Cells, Cultured; Cyclooxygenase Inhibitors; DNA Fragmentation; Dose-Response Relationship, Drug; Eicosanoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Group IB Phospholipases A2; Indolizines; Neurons; Nitrobenzenes; Phospholipases A; Phospholipases A2; Prostaglandin D2; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors | 2002 |
Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion.
Topics: 6-Ketoprostaglandin F1 alpha; Adenocarcinoma; Arachidonic Acid; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Humans; Indomethacin; Isoenzymes; Male; Membrane Proteins; Neoplasm Invasiveness; Nitrobenzenes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Prostatic Neoplasms; Sulfonamides; Tumor Cells, Cultured | 2002 |
Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors.
Topics: Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cell Survival; Cyclooxygenase 2; Dexamethasone; Dinoprostone; Flurbiprofen; Humans; Indomethacin; Isoenzymes; Lung; Membrane Proteins; Muscle, Smooth; NF-kappa B; Nitrobenzenes; Promoter Regions, Genetic; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Protein Transport; Receptors, Cytoplasmic and Nuclear; Response Elements; Sulfonamides; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation | 2003 |
Celecoxib inhibits ureteral contractility and prostanoid release.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cyclooxygenase Inhibitors; Depression, Chemical; Dimethyl Sulfoxide; Dinoprost; Dinoprostone; Gas Chromatography-Mass Spectrometry; Humans; Indomethacin; Muscle Contraction; Nitrobenzenes; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Pyrazoles; Secretory Rate; Sulfonamides; Sus scrofa; Thromboxane A2; Tumor Necrosis Factor-alpha; Ureter; Ureteral Obstruction | 2005 |
The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats.
Topics: Animals; Cerebral Cortex; Cyclooxygenase Inhibitors; Inflammation Mediators; Male; Nitrobenzenes; Nitrosation; Oxidation-Reduction; Prostaglandin D2; Rats; Rats, Wistar; Restraint, Physical; Stress, Physiological; Sulfonamides; Time Factors | 2005 |
Role of 15-deoxy delta(12,14) prostaglandin J2 and Nrf2 pathways in protection against acute lung injury.
Topics: Animals; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; DNA-Binding Proteins; Macrophages; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; Nitrobenzenes; Pneumonia; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Respiratory Distress Syndrome; Sulfonamides; Trans-Activators | 2005 |
Involvement of prostaglandins in an animal model of Shigella-related seizures.
Topics: Animals; Chi-Square Distribution; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Nitrobenzenes; Pentylenetetrazole; Prostaglandin D2; Prostaglandins; Seizures; Shigella dysenteriae; Sulfonamides | 2005 |
COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Carrageenan; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dermatitis, Atopic; Edema; Mice; Nitrobenzenes; Prostaglandin D2; Pruritus; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides | 2006 |
Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Line; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Fatty Acids, Unsaturated; Gene Expression Regulation, Enzymologic; Humans; Lipoproteins, LDL; Macrophages, Peritoneal; MAP Kinase Signaling System; Meloxicam; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitrobenzenes; p38 Mitogen-Activated Protein Kinases; PPAR alpha; PPAR gamma; Prostaglandin D2; RNA, Messenger; Sulfonamides; Thiazines; Thiazoles | 2008 |
R(+)-methanandamide-induced apoptosis of human cervical carcinoma cells involves a cyclooxygenase-2-dependent pathway.
Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acids; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; DNA Fragmentation; Dose-Response Relationship, Drug; Female; Fumonisins; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Intramolecular Oxidoreductases; Lipocalins; Nitrobenzenes; Oxidoreductases; PPAR gamma; Prostaglandin D2; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sulfonamides; Time Factors; Uterine Cervical Neoplasms | 2009 |
Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Atherosclerosis; Benzofurans; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Down-Regulation; Endothelial Cells; Epoprostenol; Heme Oxygenase-1; Humans; Inflammation; Nitrobenzenes; Perfusion; Propionates; Prostaglandin D2; Receptors, Epoprostenol; Receptors, Prostaglandin; Stress, Mechanical; Sulfonamides; Tumor Necrosis Factor-alpha; Up-Regulation | 2009 |
Simultaneous inhibition of COX-2 and activation of PPAR-γ resulted in the same level and pattern of neuroprotection as they were targeted separately.
Topics: Anilides; Animals; Apoptosis; bcl-2-Associated X Protein; Cyclooxygenase 2 Inhibitors; Hydrogen Peroxide; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Nitrobenzenes; PC12 Cells; PPAR gamma; Prostaglandin D2; Proto-Oncogene Proteins c-bcl-2; Rats; Sulfonamides | 2013 |
Lovastatin lactone elicits human lung cancer cell apoptosis via a COX-2/PPARγ-dependent pathway.
Topics: A549 Cells; Anilides; Apoptosis; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; DNA Fragmentation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Lung Neoplasms; Nitrobenzenes; PPAR gamma; Prostaglandin D2; RNA Interference; RNA, Messenger; RNA, Small Interfering; Sulfonamides | 2016 |
Macrophages programmed by apoptotic cells inhibit epithelial-mesenchymal transition in lung alveolar epithelial cells via PGE2, PGD2, and HGF.
Topics: Alveolar Epithelial Cells; Amides; Animals; Apoptosis; Culture Media, Conditioned; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Epithelial-Mesenchymal Transition; Gene Expression Regulation; Hepatocyte Growth Factor; Macrophages; Mice; Nitrobenzenes; Prostaglandin D2; Pyridines; rho GTP-Binding Proteins; rhoA GTP-Binding Protein; Sulfonamides | 2016 |
Excitotoxicity-induced prostaglandin D
Topics: Animals; Cell Death; Cyclooxygenase 2; Hippocampus; Kainic Acid; Microglia; Neurons; Nitrobenzenes; Prostaglandin D2; Rats; Sulfonamides | 2017 |